A chimeric human-mouse model of Sjögren's syndrome

Clinical Immunology

Volumn 156, Issue 1, 2015, Pages 1-8

  Young, Nicholas A ^a,b   Wu, Lai Chu ^a,b   Bruss, Michael ^a,b   Kaffenberger, Benjamin H ^a,b   Hampton, Jeffrey ^a,b   Bolon, Brad ^a,b   Jarjour, Wael N ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Animal model; Chimera; Humanized mouse; Sj gren's syndrome

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHIMERA; CYTOKINE PRODUCTION; HISTOLOGY; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOGENESIS; IN VIVO STUDY; INFLAMMATION; MOUSE; NOD SCID MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; SJOEGREN SYNDROME; ANIMAL; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOLOGY;

ANIMALS; CHIMERA; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; MICE; SJOGREN'S SYNDROME;

EID: 84909608021     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2014.10.004     Document Type: Article

References (18)

1. Ramos-Casals M., Font J. Primary Sjogren's syndrome: current and emergent aetiopathogenic concepts. Rheumatology 2005, 44:1354-1367.
2. Christodoulou M.I., Kapsogeorgou E.K., Moutsopoulos H.M. Characteristics of the minor salivary gland infiltrates in Sjogren's syndrome. J Autoimmun. 2010, 34:400-407.
3. Singh N., Cohen P.L. The T cell in Sjogren's syndrome: force majeure, not spectateur. J Autoimmun. 2012, 39:229-233.
4. Shultz L.D., Ishikawa F., Greiner D.L. Humanized mice in translational biomedical research. Nat. Rev. Immunol. 2007, 7:118-130.
5. King M., Pearson T., Shultz L.D., Leif J., Bottino R., Trucco M., et al. A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene. Clin. Immunol. 2008, 126:303-314.
6. Christianson S.W., Shultz L.D., Leiter E.H. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors. Diabetes 1993, 42:44-55.
7. Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H.M., Alexander E.L., Carsons S.E., et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann. Rheum. Dis. 2002, 61:554-558.
8. Young N.A., Friedman A.K., Kaffenberger B., Rajaram M.V., Birmingham D.J., Rovin B.H., et al. Novel estrogen target gene ZAS3 is overexpressed in systemic lupus erythematosus. Mol. Immunol. 2013, 54:23-31.
9. Young N.A., Sharma R., Friedman A.K., Kaffenberger B.H., Bolon B., Jarjour W.N. Aberrant muscle antigen exposure is sufficient to cause myositis in a regulatory T cell-deficient milieu. Arthritis Rheum 2013, 65:3259-3270.
10. Sharma R., Zheng L., Guo X., Fu S.M., Ju S.T., Jarjour W.N. Novel animal models for Sjogren's syndrome: expression and transfer of salivary gland dysfunction from regulatory T cell-deficient mice. J. Autoimmun. 2006, 27:289-296.
11. Adamson T.C., Fox R.I., Frisman D.M., Howell F.V. Immunohistologic analysis of lymphoid infiltrates in primary Sjogren's syndrome using monoclonal antibodies. J. Immunol. 1983, 130:203-208.
12. Pepose J.S., Akata R.F., Pflugfelder S.C., Voigt W. Mononuclear cell phenotypes and immunoglobulin gene rearrangements in lacrimal gland biopsies from patients with Sjogren's syndrome. Ophthalmology 1990, 97:1599-1605.
13. Rusakiewicz S., Nocturne G., Lazure T., Semeraro M., Flament C., Caillat-Zucman S., et al. NCR3/NKp30 contributes to pathogenesis in primary Sjogren's syndrome. Sci. Transl. Med. 2013, 5. (195ra96.).
14. Villarreal G.M., Alcocer-Varela J., Llorente L. Cytokine gene and CD25 antigen expression by peripheral blood T cells from patients with primary Sjogren's syndrome. Autoimmunity 1995, 20:223-229.
15. Kang E.H., Lee Y.J., Hyon J.Y., Yun P.Y., Song Y.W. Salivary cytokine profiles in primary Sjogren's syndrome differ from those in non-Sjogren sicca in terms of TNF-alpha levels and Th-1/Th-2 ratios. Clin. Exp. Rheumatol. 2011, 29:970-976.
16. Cha S., Brayer J., Gao J., Brown V., Killedar S., Yasunari U., et al. A dual role for interferon-gamma in the pathogenesis of Sjogren's syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse. Scand. J. Immunol. 2004, 60:552-565.
17. Perrier S., Serre A.F., Dubost J.J., Beaujon G., Plazonnet M.P., Albuisson E., et al. Increased serum levels of interleukin 10 in Sjogren's syndrome; correlation with increased IgG1. J. Rheumatol. 2000, 27:935-939.
18. Sharif M.N., Tassiulas I., Hu Y., Mecklenbrauker I., Tarakhovsky A., Ivashkiv L.B. IFN-alpha priming results in a gain of proinflammatory function by IL-10: implications for systemic lupus erythematosus pathogenesis. J. Immunol. 2004, 172:6476-6481.